JAFRAL Heads to ESCMID 2025 in Vienna
#JAFRAL is excited to announce its participation in the ESCMID – European Society of Clinical Microbiology and Infectious Diseases Conference, taking place in Vienna from April 11–15, 2025.
You can find us at Booth K50, where our CEO, Frenk Smrekar, and COO, Barbara Hubad, will be available to discuss the future of phage therapy and its critical role in combating antimicrobial resistance (AMR).
The ESCMID conference is a premier gathering for experts in clinical microbiology and infectious diseases, providing an ideal platform to exchange knowledge, showcase innovations, and explore collaborative opportunities in the fight against antibiotic-resistant infections.
We look forward to connecting with peers, sharing insights, and advancing the development of phage-based solutions to meet pressing global health challenges.
